vs

Side-by-side financial comparison of InfuSystem Holdings, Inc (INFU) and RMR GROUP INC. (RMR). Click either name above to swap in a different company.

RMR GROUP INC. is the larger business by last-quarter revenue ($66.7M vs $36.2M, roughly 1.8× InfuSystem Holdings, Inc). On growth, RMR GROUP INC. posted the faster year-over-year revenue change (40.8% vs 7.0%).

InfuSystem Holdings, Inc. is a U.S.-headquartered healthcare provider specializing in infusion therapy solutions. It supplies programmable infusion pumps, matching disposable medical consumables, and professional clinical support services, serving oncology clinics, home healthcare providers, and acute care facilities across North America.

RMR Group Inc. is a U.S.-headquartered alternative asset management firm specializing in real estate and real estate-related investments. It operates across commercial property, residential real estate, and infrastructure segments, serving institutional investors, high-net-worth individuals, and retail clients across key global markets.

INFU vs RMR — Head-to-Head

Bigger by revenue
RMR
RMR
1.8× larger
RMR
$66.7M
$36.2M
INFU
Growing faster (revenue YoY)
RMR
RMR
+33.7% gap
RMR
40.8%
7.0%
INFU

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
INFU
INFU
RMR
RMR
Revenue
$36.2M
$66.7M
Net Profit
$12.2M
Gross Margin
56.4%
Operating Margin
10.3%
48.1%
Net Margin
18.3%
Revenue YoY
7.0%
40.8%
Net Profit YoY
91.1%
EPS (diluted)
$0.09
$0.71

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
INFU
INFU
RMR
RMR
Q4 25
$36.2M
$66.7M
Q3 25
$36.5M
Q2 25
$36.0M
Q1 25
$34.7M
Q4 24
$33.8M
Q3 24
$35.3M
Q2 24
$33.7M
Q1 24
$32.0M
Net Profit
INFU
INFU
RMR
RMR
Q4 25
$12.2M
Q3 25
$2.3M
Q2 25
$2.6M
Q1 25
$-267.0K
Q4 24
Q3 24
$1.8M
Q2 24
$717.0K
Q1 24
$-1.1M
Gross Margin
INFU
INFU
RMR
RMR
Q4 25
56.4%
Q3 25
57.1%
Q2 25
55.2%
Q1 25
55.2%
Q4 24
53.8%
Q3 24
53.9%
Q2 24
49.5%
Q1 24
51.5%
Operating Margin
INFU
INFU
RMR
RMR
Q4 25
10.3%
48.1%
Q3 25
10.4%
Q2 25
10.5%
Q1 25
1.8%
Q4 24
7.7%
Q3 24
9.2%
Q2 24
5.5%
Q1 24
-2.6%
Net Margin
INFU
INFU
RMR
RMR
Q4 25
18.3%
Q3 25
6.2%
Q2 25
7.2%
Q1 25
-0.8%
Q4 24
Q3 24
5.1%
Q2 24
2.1%
Q1 24
-3.5%
EPS (diluted)
INFU
INFU
RMR
RMR
Q4 25
$0.09
$0.71
Q3 25
$0.11
Q2 25
$0.12
Q1 25
$-0.01
Q4 24
$0.05
Q3 24
$0.08
Q2 24
$0.03
Q1 24
$-0.05

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
INFU
INFU
RMR
RMR
Cash + ST InvestmentsLiquidity on hand
$3.2M
$49.3M
Total DebtLower is stronger
$19.6M
Stockholders' EquityBook value
$57.3M
$232.7M
Total Assets
$100.6M
$687.1M
Debt / EquityLower = less leverage
0.34×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
INFU
INFU
RMR
RMR
Q4 25
$3.2M
$49.3M
Q3 25
$955.0K
Q2 25
$720.0K
Q1 25
$1.5M
Q4 24
$527.0K
Q3 24
$380.0K
Q2 24
$146.0K
Q1 24
$822.0K
Total Debt
INFU
INFU
RMR
RMR
Q4 25
$19.6M
Q3 25
$20.9M
Q2 25
$26.3M
Q1 25
$28.7M
Q4 24
$23.9M
Q3 24
$28.0M
Q2 24
$34.2M
Q1 24
$29.9M
Stockholders' Equity
INFU
INFU
RMR
RMR
Q4 25
$57.3M
$232.7M
Q3 25
$55.5M
Q2 25
$54.5M
Q1 25
$55.1M
Q4 24
$57.5M
Q3 24
$55.5M
Q2 24
$53.5M
Q1 24
$52.3M
Total Assets
INFU
INFU
RMR
RMR
Q4 25
$100.6M
$687.1M
Q3 25
$98.9M
Q2 25
$100.8M
Q1 25
$104.3M
Q4 24
$103.6M
Q3 24
$105.3M
Q2 24
$108.5M
Q1 24
$104.8M
Debt / Equity
INFU
INFU
RMR
RMR
Q4 25
0.34×
Q3 25
0.38×
Q2 25
0.48×
Q1 25
0.52×
Q4 24
0.41×
Q3 24
0.50×
Q2 24
0.64×
Q1 24
0.57×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
INFU
INFU
RMR
RMR
Operating Cash FlowLast quarter
$7.1M
$10.7M
Free Cash FlowOCF − Capex
$7.0M
FCF MarginFCF / Revenue
19.3%
Capex IntensityCapex / Revenue
0.4%
Cash ConversionOCF / Net Profit
0.88×
TTM Free Cash FlowTrailing 4 quarters
$23.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
INFU
INFU
RMR
RMR
Q4 25
$7.1M
$10.7M
Q3 25
$8.5M
Q2 25
$7.0M
Q1 25
$1.8M
Q4 24
$7.9M
Q3 24
$9.8M
Q2 24
$2.3M
Q1 24
$377.0K
Free Cash Flow
INFU
INFU
RMR
RMR
Q4 25
$7.0M
Q3 25
$8.4M
Q2 25
$6.8M
Q1 25
$1.6M
Q4 24
$7.4M
Q3 24
$9.8M
Q2 24
$2.0M
Q1 24
$195.0K
FCF Margin
INFU
INFU
RMR
RMR
Q4 25
19.3%
Q3 25
23.1%
Q2 25
18.9%
Q1 25
4.7%
Q4 24
21.9%
Q3 24
27.7%
Q2 24
5.9%
Q1 24
0.6%
Capex Intensity
INFU
INFU
RMR
RMR
Q4 25
0.4%
Q3 25
0.2%
Q2 25
0.6%
Q1 25
0.4%
Q4 24
1.6%
Q3 24
0.1%
Q2 24
1.0%
Q1 24
0.6%
Cash Conversion
INFU
INFU
RMR
RMR
Q4 25
0.88×
Q3 25
3.76×
Q2 25
2.70×
Q1 25
Q4 24
Q3 24
5.45×
Q2 24
3.22×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

INFU
INFU

Patient Services$20.0M55%
Device Solutions$14.4M40%
Other$1.9M5%

RMR
RMR

Management Service Incentive$23.6M35%
Industrial Logistics Properties Trust$15.1M23%
Managed Private Real Estate Capital$11.1M17%
Office Properties Income Trust$5.6M8%
Other Private Entities$5.3M8%
RMR Residential$3.4M5%
Sonesta International Hotels Corporation$2.1M3%
Investment Advisory Management And Administrative Service$1.2M2%

Related Comparisons